Dosage & Administration Drug label Prior authorization Financial assistance

Kimyrsa

(oritavancin)

oritavancin 1200 MG Injection [Kimyrsa]

NO BLACK BOX WARNING

Dosage & administration

* There are two oritavancin products (KIMYRSA and ORBACTIV®, another oritavancin product) that have differences in dose strength, duration of infusion and preparation instructions, including reconstitution and dilution instructions and compatible diluents
* Administer 1,200 mg of KIMYRSA as a single dose by intravenous infusion over 1 hour.
* Carefully follow the recommended dosage and dose preparation instructions for KIMYRSA in the full prescribing information.

drug label

Kimyrsa prescribing information

Have more Kimyrsa questions?

Submit MSL Request

Learn More

Need to report a Kimyrsa issue?

ONLINE FORMReport adverse event

Learn More

prior authorization

Kimyrsa Prior authorization resources

NOT PROVIDED BY BRANDComplete Letter of Medical Necessity

NOT PROVIDED BY BRANDCoverage Authorization Request

NOT PROVIDED BY BRANDComplete Coverage Authorization appeals

NOT PROVIDED BY BRANDCoverage Authorization Appeal

Learn More

Benefits investigation

Kimyrsa Healthcare Provider Request Form

Learn More

Reimbursement help (FRM)

NOT PROVIDED BY BRANDReimbursement help (FRM) resources

Learn More

financial assistance

Kimyrsa Financial assistance options

Co-pay savings program

commercial only

Kimyrsa Healthcare Provider Request Form

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

Kimyrsa Healthcare Provider Request Form

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Kimyrsa Patient education

Getting started on Kimyrsa

NOT PROVIDED BY BRANDInstructions For Use: Acute Bacterial Skin and Skin Structure Infections

Patient toolkit

Patient Brochure

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Learn More

Kimyrsa FAQs

FAQ Data Source

Can't find what you're looking for?

Our trained staff can help you:

Please note:

Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
Samples are provided at the discretion of the brand.
We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.

Kimyrsa

Dosage & administration

drug label

Kimyrsa prescribing information

Have more Kimyrsa questions?

Need to report a Kimyrsa issue?

prior authorization

Kimyrsa Prior authorization resources

Benefits investigation

Reimbursement help (FRM)

financial assistance

Kimyrsa Financial assistance options

Co-pay savings program

Bridge program

Foundation programs

patient education

Kimyrsa Patient education

Getting started on Kimyrsa

Patient toolkit

people also ask

Kimyrsa FAQs

Can't find what you're looking for?